Health Care

Hawley Secures Pledge from RFK to Review ‘Alarming’ Mifepristone Data, Support Bill Cracking Down on Big Pharma Ads

Today in a Senate Health, Education, Labor and Pensions Committee hearing, U.S. Senator Josh Hawley (R-Mo.) secured a commitment from Health and Human Services Secretary Robert F. Kennedy (RFK) Jr. that he would review ‘alarming’ new data on the chemical abortion drug mifepristone. RFK Jr. also stated that in light of the new data, the Food and Drug Administration (FDA) label for mifepristone should change to accurately reflect the adverse effects of the drug....

read more

Hawley Blasts Pharmacy Benefit Managers for ‘Screwing’ Patients, Calls for Breaking Up ‘Pharma Monopoly’

Today, U.S. Senator Josh Hawley (R-Mo.) blasted pharmacy benefit managers (PBMs) for raising drug prices and profiting at the expense of Missourians.  https://twitter.com/HawleyMO/status/1922327186574327897 Senator Hawley grilled Pharmaceutical Care Management Association (PCMA) President J.C. Scott, questioning why Americans pay 422% more than other countries for the same brand name prescription drugs. “You’re supposed to be making drugs more affordable for consumers – would you say that you...

read more

Hawley Statement in Support of Reining in Prescription Drug Prices

Today U.S. Senator Josh Hawley (R-Mo.) released the following statement in support of President Trump's executive order to lower prescription drug prices. Last week, Senator Hawley introduced the bipartisan Fair Prescription Drug Prices for Americans Act, which would offer relief for millions of patients while ensuring Americans are no longer financing lower drug costs for foreigners. https://twitter.com/HawleyMO/status/1921950612104601836

read more

Hawley Op-Ed: Don’t Cut Medicaid

By U.S. Senator Josh Hawley (R-Mo.) | May 12, 2025 | The New York Times Polls show Democrats down in the dumps at their lowest approval level in decades, but we Republicans are having an identity crisis of our own, and you can see it in the tug of war over President Trump’s “one big, beautiful bill.” The nub of the conflict: Will Republicans be a majority party of working people, or a permanent minority speaking only for the C suite?Mr. Trump has promised working-class tax cuts and protection...

read more

Hawley Secures Commitment from RFK’s Deputy Nominee to Review Chemical Abortion Data

Today in a hearing in the Senate Committee on Health, Education, Labor and Pensions, U.S. Senator Josh Hawley (R-Mo.) secured a commitment from Jim O’Neill – President Trump’s nominee to serve as Deputy Secretary of Health and Human Services – to conduct an updated safety review on the chemical abortion drug mifepristone if he were confirmed. The promise comes on the heels of a new study showing that 1 in 10 women who take the drug suffer from adverse health effects.O’Neill agreed with Senator...

read more

Hawley Introduces Legislation to Reinstate Safety Regulations on Chemical Abortion Drug Mifepristone

Today, U.S. Senator Josh Hawley (R-Mo.) introduced the Restoring Safeguards for Dangerous Abortion Drugs Act to reinstate safety regulations on the chemical abortion drug mifepristone. The legislation comes after a recent study revealed 1 in 10 women who take the drug experience adverse health effects. “I’m introducing the Restoring Safeguards for Dangerous Abortion Drugs Act after a bombshell study revealed the truth about mifepristone: it’s...

read more

In Bipartisan Push, Hawley & Welch Introduce Major Legislation to Lower Prescription Drug Prices

Today U.S. Senator Josh Hawley (R-Mo.) and Senator Peter Welch (D-Vt.) introduced legislation to lower the cost of drug prices for Americans. The Fair Prescription Drug Prices for Americans Act would offer relief for millions of patients while ensuring Americans are no longer financing lower drug costs for foreigners.This legislation would correct decades of policies that benefited pharmaceutical companies but left American patients holding the bag. While other...

read more

Hawley Op-Ed: FDA Commissioner Can’t Ignore Damning New Data on Dangers of Mifepristone

Today, U.S Senator Josh Hawley (R-Mo.) published an opinion piece outlining why Food and Drug Administration (FDA) Commissioner Marty Makary must reinstate safety regulations surrounding the chemical abortion drug mifepristone. The op-ed comes after a bombshell report revealed the dangers of mifepristone, including that 1 in 10 women who take the pill suffer an "adverse health event," including sepsis, hemorrhaging or an emergency room visit.  Read the...

read more

Hawley Calls on FDA to Reinstate Abortion Drug Safety Regulations: ‘The Time to Act is Now’

Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Food and Drug Administration (FDA) Commissioner Marty Makary about new research showing that the safety risks of the chemical abortion drug mifepristone are far greater than the FDA currently acknowledges. Senator Hawley points to Dr. Makary’s recent comments that he has “no plans to take action” on mifepristone and urges him to reconsider in light of this new data.In his letter, Senator Hawley recounts an exchange he...

read more

Hawley Acts to Ensure Dr. Oz Aligns with President Trump’s Positions

Following Dr. Mehmet Oz’s confirmation hearing today in the Senate Finance Committee, U.S. Senator Josh Hawley (R-Mo.) directed a list of written questions to Dr. Oz. Senator Hawley’s request for answers comes after he expressed previous concerns about Dr. Oz’s ability to deliver on President Trump’s agenda, especially regarding transgender and pro-life policies. Some of Senator Hawley’s questions to Dr. Oz include: On your television program, you hosted various transgender advocates as well...

read more